Stay updated on Tilsotolimod Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Tilsotolimod Combo Therapy Clinical Trial page.

Latest updates to the Tilsotolimod Combo Therapy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.1 was introduced, replacing v3.4.0. No changes to the study content or other user-facing information were observed.SummaryDifference0.1%

- Check13 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deletions remove Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a new revision label, v3.3.4, replacing v3.3.3; this appears to be a minor update with no impact on displayed study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedA dedicated Locations section now lists Arizona, California, and Texas, replacing the prior state-specific headers (Arizona Locations, California Locations, Texas Locations). The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check70 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No changes to study details, eligibility criteria, endpoints, or locations.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. This appears to be a minor documentation update with no visible changes to study information.SummaryDifference0.1%

Stay in the know with updates to Tilsotolimod Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tilsotolimod Combo Therapy Clinical Trial page.